comparemela.com

Latest Breaking News On - Nasdaq dxcm - Page 3 : comparemela.com

DexCom (NASDAQ:DXCM) Posts Earnings Results, Beats Expectations By $0 05 EPS

DexCom (NASDAQ:DXCM – Get Free Report) released its quarterly earnings data on Thursday. The medical device company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05, reports. DexCom had a return on equity of 31.38% and a net margin of 16.82%. The firm had revenue of $921.00 million […]

DexCom (NASDAQ:DXCM) Announces Earnings Results, Beats Estimates By $0 05 EPS

DexCom (NASDAQ:DXCM – Get Free Report) announced its quarterly earnings results on Thursday. The medical device company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05, reports. The firm had revenue of $921.00 million for the quarter, compared to analyst estimates of $911.20 million. DexCom had a net […]

C WorldWide Group Holding A S Has $47 65 Million Position in DexCom, Inc (NASDAQ:DXCM)

C WorldWide Group Holding A S boosted its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.2% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 384,000 shares of the medical device company’s stock after purchasing an additional 12,000 shares during the period. DexCom […]

California Public Employees Retirement System Has $85 83 Million Stake in DexCom, Inc (NASDAQ:DXCM)

California Public Employees Retirement System decreased its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 691,682 shares of the medical device company’s stock after selling 25,161 shares during the […]

Bailard Inc Has $6 91 Million Position in DexCom, Inc (NASDAQ:DXCM)

Bailard Inc. reduced its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 15.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 55,668 shares of the medical device company’s stock after selling 9,850 shares during the period. Bailard Inc.’s holdings […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.